BR112018005457A2 - peptídeo cíclico, composição cosmética ou dermatológica, e, loção para os olhos. - Google Patents

peptídeo cíclico, composição cosmética ou dermatológica, e, loção para os olhos.

Info

Publication number
BR112018005457A2
BR112018005457A2 BR112018005457-7A BR112018005457A BR112018005457A2 BR 112018005457 A2 BR112018005457 A2 BR 112018005457A2 BR 112018005457 A BR112018005457 A BR 112018005457A BR 112018005457 A2 BR112018005457 A2 BR 112018005457A2
Authority
BR
Brazil
Prior art keywords
cyclic peptide
cosmetic
dermatological composition
eye lotion
oocyte
Prior art date
Application number
BR112018005457-7A
Other languages
English (en)
Other versions
BR112018005457A8 (pt
Inventor
Wolf Jean-Philippe
Lombès Anne
Bomsel Morgane
Original Assignee
Assistance Publique - Hopitaux De Paris
Universite Paris Descartes
Inserm Paris
Centre National De La Recherche Scientifique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assistance Publique - Hopitaux De Paris, Universite Paris Descartes, Inserm Paris, Centre National De La Recherche Scientifique filed Critical Assistance Publique - Hopitaux De Paris
Publication of BR112018005457A2 publication Critical patent/BR112018005457A2/pt
Publication of BR112018005457A8 publication Critical patent/BR112018005457A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B63—SHIPS OR OTHER WATERBORNE VESSELS; RELATED EQUIPMENT
    • B63B—SHIPS OR OTHER WATERBORNE VESSELS; EQUIPMENT FOR SHIPPING 
    • B63B21/00—Tying-up; Shifting, towing, or pushing equipment; Anchoring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B63—SHIPS OR OTHER WATERBORNE VESSELS; RELATED EQUIPMENT
    • B63B—SHIPS OR OTHER WATERBORNE VESSELS; EQUIPMENT FOR SHIPPING 
    • B63B21/00—Tying-up; Shifting, towing, or pushing equipment; Anchoring
    • B63B2021/003—Mooring or anchoring equipment, not otherwise provided for
    • B63B2021/004—Quick release elements in mooring connections

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Birds (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Combustion & Propulsion (AREA)
  • Ocean & Marine Engineering (AREA)
  • Mechanical Engineering (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

a invenção se refere ao uso de um peptídeo cíclico compreendendo o tripeptídeo reproduzindo um local de ligação de beta fertilina ao oócito integrina, para melhorar metabolismo de energia celular. mais particularmente, a invenção diz respeito ao uso de um peptídeo cíclico compreendendo o tripeptídeo feec para estimular o metabolismo de energia dos gametas ou células embrionárias no contexto de protocolos de procriação medicamente assistida (map), em particular promovendo a maturação in vitro do oócito, a taxa de fertilização e a taxa de nascimento.
BR112018005457A 2015-09-21 2016-09-21 Peptídeo cíclico, composição cosmética ou dermatológica, e, loção para os olhos. BR112018005457A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1558899 2015-09-21
FR1558899A FR3041260B1 (fr) 2015-09-21 2015-09-21 Utilisation d'un tripeptide cyclique pour stimuler l'activite mitochondriale de cellules
PCT/EP2016/072476 WO2017050854A1 (fr) 2015-09-21 2016-09-21 Utilisation d'un tripeptide cyclique pour ameliorer le metabolisme energetique cellulaire

Publications (2)

Publication Number Publication Date
BR112018005457A2 true BR112018005457A2 (pt) 2018-10-09
BR112018005457A8 BR112018005457A8 (pt) 2022-11-08

Family

ID=56263743

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018005457A BR112018005457A8 (pt) 2015-09-21 2016-09-21 Peptídeo cíclico, composição cosmética ou dermatológica, e, loção para os olhos.

Country Status (16)

Country Link
US (1) US11278589B2 (pt)
EP (1) EP3352775B1 (pt)
JP (1) JP6918804B2 (pt)
KR (1) KR20180133373A (pt)
CN (1) CN109069579B (pt)
AU (1) AU2016325378B2 (pt)
BR (1) BR112018005457A8 (pt)
CA (1) CA2998747A1 (pt)
ES (1) ES2969739T3 (pt)
FR (1) FR3041260B1 (pt)
HK (1) HK1258383A1 (pt)
IL (1) IL258178B2 (pt)
MA (1) MA42928B1 (pt)
RU (1) RU2737116C2 (pt)
WO (1) WO2017050854A1 (pt)
ZA (1) ZA201802132B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019097290A1 (en) * 2017-11-15 2019-05-23 Aratinga.Bio Enhancement of biologics production in cell culture systems by fertilin-derived peptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2862225B1 (fr) 2003-11-19 2006-06-02 Univ Paris 13 Peptide augmentant la capacite fusiogene de l'ovocyte
ITMI20040255A1 (it) * 2004-02-17 2004-05-17 Univ Degli Studi Milano Sostanze ad attivita' antiangiogenica
RU2005128993A (ru) * 2005-09-08 2007-03-20 Общество С Ограниченной Ответственностью Исследовательский Центр "Комкон" (Ru) Средство для коррекции стресс-индуцируемых нейромедиаторных, нейроэндокринных и метаболических нарушений, а также способ профилактики и лечения сопутствующих им паталогических состояний

Also Published As

Publication number Publication date
RU2737116C2 (ru) 2020-11-24
WO2017050854A1 (fr) 2017-03-30
CN109069579B (zh) 2022-04-29
BR112018005457A8 (pt) 2022-11-08
ES2969739T3 (es) 2024-05-22
IL258178B1 (en) 2023-11-01
JP2018536013A (ja) 2018-12-06
FR3041260A1 (fr) 2017-03-24
MA42928B1 (fr) 2024-01-31
MA42928A (fr) 2018-08-01
EP3352775B1 (fr) 2023-11-01
AU2016325378A1 (en) 2018-04-19
AU2016325378B2 (en) 2020-08-20
RU2018114660A (ru) 2019-10-23
IL258178B2 (en) 2024-03-01
CN109069579A (zh) 2018-12-21
RU2018114660A3 (pt) 2020-03-02
ZA201802132B (en) 2019-09-25
CA2998747A1 (fr) 2017-03-30
US11278589B2 (en) 2022-03-22
KR20180133373A (ko) 2018-12-14
HK1258383A1 (zh) 2019-11-08
EP3352775C0 (fr) 2023-11-01
EP3352775A1 (fr) 2018-08-01
US20180264075A1 (en) 2018-09-20
JP6918804B2 (ja) 2021-08-11
FR3041260B1 (fr) 2020-10-02
IL258178A (en) 2018-05-31

Similar Documents

Publication Publication Date Title
ECSP20075163A (es) Moléculas de unión contra bcma y usos de las mismas
BR112018005110A2 (pt) Composição emoliente e sua utilização cosmética, composição cosmética, dermatológica ou farmacêutica e sua utilização cosmética e processo de tratamento cosmético da pele
BR112014006158A2 (pt) molécula de ligação, molécula de ácido nucléico, vetor, célula hospedeira, processo para preparar uma molécula de ligação, métodos para acentuar uma resposta imune em um indivíduo humano, para tratar câncer em um indivíduo humano em necessidade do mesmo, para reduzir o tamanho de um tumor ou inibir o crescimento de células cancerosas em um indivíduo ou reduzir ou inibir o desenvolvimento do câncer metastático em um indivíduo sofrendo de câncer, uso de uma molécula de ligação, e, composição farmacêutica
BR112015005301A2 (pt) composições cosméticas biofotônicas
AR093377A1 (es) Anticuerpos anti-notch y conjugados de anticuerpo-farmaco
BR112018013407A2 (pt) anticorpos e conjugados dos mesmos
BR112016027585A2 (pt) construções de anticorpo multiespecíficas
BR112016007622A2 (pt) composto, composição farmacêutica, conjugado de ligante-droga, e, método para tratar câncer
AR080873A1 (es) Anticuerpos contra factor de crecimiento epidermico (anti-erbb3 o anti-her3)
BR112017008344A2 (pt) extrato, uso de um extrato, e, composição cosmética ou dermofarmacêutica.
CL2012002416A1 (es) Proteina de union capaz de unirse a dll4; construccion de anticuerpo que comprende dicha proteina; conjugado de anticuerpo; acido nucleico, vector y celula huesped que comprenden el anticuerpo; composicion para la liberacion de una proteina de union; metodo para reducir la actividad del dll4 humano.
BR112014026990A2 (pt) anticorpo , ácido nucleico , vetores , célula hospedeira , composição farmacêutica , uso de um anticorpo e método para o tratamento de um paciente com necessidade de terapia.
BR112012013717A2 (pt) "anticorpo de ligação ao csf-1r humano, composição farmacêutica, ácido nuleico, vetor de expressão, célula hospedeira procariótica ou eucariótica , método para a produção de um anticorpo recombinate, uso do anticorpo emétodo para o tratamento de um paciente qur sofre de câncer, de metástase e de doenças inflamatórias"
BR112014018728A8 (pt) Compostos de purinonas como inibidores de quinase
BR112014005355A2 (pt) células t de memória central anti-terceiro, métodos de produção e uso das mesmas em transplante e tratamento de doença
EP2575856A4 (en) INNOVATIVE DISCOVERY OF THERAPEUTIC COMPOSITIONS, DIAGNOSTICS AND ANTIBODIES RELATED TO PROTEIN FRAGMENTS OF GLUTAMINYL-ARNT SYNTHETASES
EA201492040A1 (ru) Бициклически замещённые урацилы и их применение
BR112017023391A2 (pt) ?composição, método para preparar uma composição e métodos para melhorar a hidratação da pele?
BR112015005653A8 (pt) estimulação de desenvolvimento de folículo ovariano e maturação de oócitos
CL2015002692A1 (es) Novedosos compuestos de bencenosulfonamida, método para sintetizarlos y uso de los compuestos en medicina y en cosméticos.
DOP2015000211A (es) Anticuerpos anti-cd52
BR112017001696A2 (pt) composições de célula-tronco e métodos de produção de células-tronco para aplicações terapêuticas
WO2015001013A3 (en) Human anti-ifn-alpha antibodies
BR112018006152A2 (pt) uso de células matriciais, processo ?in vitro? para preparar um microfolículo de cabelo, microfolículo de cabelo, uso de um microfolículo de cabelo e processo de triagem de produtos
BR112018005457A2 (pt) peptídeo cíclico, composição cosmética ou dermatológica, e, loção para os olhos.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B25A Requested transfer of rights approved

Owner name: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (FR) ; INSERM PARIS (FR) ; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) ; UNIVERSITE DE PARIS (FR)

B25D Requested change of name of applicant approved

Owner name: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (FR) ; INSERM PARIS (FR) ; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) ; UNIVERSITE PARIS CITE (FR)